Cas:170570-01-1 4-Desmethyl-3-methyl Celecoxib manufacturer & supplier

Chemical Name:4-Desmethyl-3-methyl Celecoxib

CAS.NO:170570-01-1

Synonyms:4-[5-(3-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide;Celecoxib impurity A;4-[5-(3-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide;Celecoxib Impurity 3

Molecular Formula:C₁₇H₁₄F₃N₃O₂S

Molecular Weight:381.37200

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:86.36000

Exact Mass:381.07600

LogP:5.29500

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 4-[5-(3-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Celecoxib Impurity 3 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-[5-(3-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide Use and application,Celecoxib impurity A technical grade,usp/ep/jp grade.

Related News: From the three-month point onward, 84.5% of uMRD patients maintained that deep remission in the blood to the 12-month assessment. These data show the new combo can deliver “very durable remissions” for the vast majority of patients, Tendler said. 4-Desmethyl-3-methyl Celecoxib manufacturer For one, people who are surrounded by others of similar body size may not perceive their weight to be outside of the norm and therefore not seek out bariatric surgery,” said Sandon. “[And] there are differences in ethnicities and culture between states with the highest rates of obesity compared to states with lower rates. 4-Desmethyl-3-methyl Celecoxib supplier For one, people who are surrounded by others of similar body size may not perceive their weight to be outside of the norm and therefore not seek out bariatric surgery,” said Sandon. “[And] there are differences in ethnicities and culture between states with the highest rates of obesity compared to states with lower rates. 4-Desmethyl-3-methyl Celecoxib vendor From the three-month point onward, 84.5% of uMRD patients maintained that deep remission in the blood to the 12-month assessment. These data show the new combo can deliver “very durable remissions” for the vast majority of patients, Tendler said. 4-Desmethyl-3-methyl Celecoxib factory In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China.